blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1339396

EP1339396 - MAGNETIC PARTICLES FOR THE TARGETED REGIONAL THERAPY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.07.2005
Database last updated on 13.09.2024
Most recent event   Tooltip01.07.2005Application deemed to be withdrawnpublished on 17.08.2005  [2005/33]
Applicant(s)For all designated states
Alexiou, Christoph
Elisabethstrasse 8
80796 München / DE
For all designated states
Bergemann, Christian
Bamberger Strasse 51
10777 Berlin 31 / DE
[2003/36]
Inventor(s)01 / see applicant
...
 [2003/36]
Representative(s)Leson, Thomas Johannes Alois
TBK
Bavariaring 4-6
80336 München / DE
[N/P]
Former [2003/36]Leson, Thomas Johannes Alois, Dipl.-Ing.
Tiedtke-Bühling-Kinne & Partner GbR, TBK-Patent, Bavariaring 4
80336 München / DE
Application number, filing date01998333.728.11.2001
[2003/36]
WO2001EP13926
Priority number, dateDE200015915129.11.2000         Original published format: DE 10059151
[2003/36]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO0243708
Date:06.06.2002
Language:DE
[2002/23]
Type: A2 Application without search report 
No.:EP1339396
Date:03.09.2003
Language:DE
The application published by WIPO in one of the EPO official languages on 06.06.2002 takes the place of the publication of the European patent application.
[2003/36]
Search report(s)International search report - published on:EP06.09.2002
ClassificationIPC:A61K9/50, A61K47/48, A61P35/00
[2003/36]
CPC:
A61K47/6923 (EP); A61K9/0009 (EP); A61K9/5115 (EP);
A61P35/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/36]
TitleGerman:MAGNETISCHE PARTIKEL ZUR ZIELGERICHTETEN REGIONALEN THERAPIE[2003/36]
English:MAGNETIC PARTICLES FOR THE TARGETED REGIONAL THERAPY[2003/36]
French:PARTICULES MAGN TIQUES POUR TH RAPIES LOCALES CIBL ES[2003/36]
Entry into regional phase26.06.2003National basic fee paid 
26.06.2003Designation fee(s) paid 
26.06.2003Examination fee paid 
Examination procedure28.06.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.06.2003Amendment by applicant (claims and/or description)
26.06.2003Examination requested  [2003/36]
20.10.2004Despatch of a communication from the examining division (Time limit: M04)
12.04.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2005/33]
23.06.2005Application deemed to be withdrawn, date of legal effect  [2005/33]
Fees paidRenewal fee
28.11.2003Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.11.200404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XD]DE19624426  (BERGEMANN CHRISTIAN [DE]) [XD] 1-17 * column 1, line 67 - column 2, line 1 *;
 [X]US5928958  (PILGRIMM HERBERT [DE]) [X] 1-17 * the whole document *;
 [PX]WO0156546  (UNIV FLORIDA STATE RES FOUND [US], et al) [PX] 1-17 * the whole document *;
 [PX]  - ALEXIOU CHRISTOPH ET AL, "Locoregional cancer treatment with magnetic drug targeting.", CANCER RESEARCH, (20001201), vol. 60, no. 23, ISSN 0008-5472, pages 6641 - 6648, XP001063184 [PX] 1-17 * the whole document *
 [X]  - ALEXIOU C ET AL, "Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting", JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (2001), vol. 225, no. 1-2, ISSN 0304-8853, pages 187 - 193, XP004234944 [X] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0304-8853(00)01256-7
 [X]  - LUBBE A S ET AL, "Physiological aspects in magnetic drug-targeting", JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (199904), vol. 194, no. 1-3, ISSN 0304-8853, pages 149 - 155, XP004166660 [X] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0304-8853(98)00574-5
 [X]  - ALEXIOU CHRISTOPH ET AL, "Magnetic drug targeting: An interdisciplinary method in treatment of cancer.", EUROPEAN BIOPHYSICS JOURNAL, 3rd European Biophysics Congress;Munchen, Germany; September 09-13, 2000, (2000), vol. 29, no. 4-5, ISSN 0175-7571, page 364, XP001068473 [X] 1-17 * abstract *
 [X]  - GUPTA P K ET AL, "MAGNETICALLY CONTROLLED TARGETED MICRO-CARRIER SYSTEMS", LIFE SCIENCES, (1989), vol. 44, no. 3, ISSN 0024-3205, pages 175 - 186, XP002197845 [X] 1-17 * page 175, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/0024-3205(89)90593-6
 [X]  - GUPTA P K ET AL, "TARGETED DELIVERY OF LOW DOSE DOXORUBICIN HYDROCHLORIDE ADMINISTERED VIA MAGNETIC ALBUMIN MICROSPHERES IN RATS", JOURNAL OF MICROENCAPSULATION, (1990), vol. 7, no. 1, ISSN 0265-2048, pages 85 - 94, XP002197846 [X] 1-17 * abstract *
 [X]  - PULFER S K; GALLO J M, "Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres", JOURNAL OF DRUG TARGETING, (1998), vol. 3, no. 6, pages 215 - 227, XP002197847 [X] 1-17 * abstract *
 [X]  - PULFER S K; CICCOTTO S L; GALLO J M, "Distribution of small magnetic particles in brain tumor-bearing rats.", JOURNAL OF NEURO-ONCOLOGY, (199901), vol. 41, no. 2, pages 99 - 105, XP002197848 [X] 1-17 * abstract *

DOI:   http://dx.doi.org/10.1023/A:1006137523591
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.